European Medicines Agency studying the need for COVID-19 booster dose
Category: #health  | By Nikita Chaurasia  | Date: 2021-09-08 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

European Medicines Agency studying the need for COVID-19 booster dose

The European Medicines Agency has advanced the evaluation on the need to recommend a booster dose of the COVID-19 vaccine made by Pfizer-BioNTech.

The EU drug regulator stated that it is considering the necessity of the third dose of the vaccine six months after the first two doses, to people aged 16 and above, to restore protection after its efficacy decreases.

EMA's experts are expediting the assessment of the data submitted by Pfizer and BioNTech, involving details of the results from a present trial in which around 300 healthy adults were given a booster shot six months after their second dose.

Pfizer has already applied for authorization of a third dose to the U.S. Food and Drug Administer and the U.S. government stated last month that the booster doses would mostly be available by the end of September.

Meanwhile, Israel has already begun administering boosters and the plan is under consideration in other countries that have vulnerable populations, including Germany and France.

The Amsterdam-based EMA mentioned that it anticipates deciding whether or not to advise a third dose of the Pfizer vaccine in the coming weeks. It stated that it was also examining the use of a third dose of the coronavirus vaccines manufactured by Pfizer-BioNTech and Moderna in people having weak immune systems, suggesting a need for an extra dose as a part of their primary vaccination programs.

It is to be noted that the World Health Organization has requested rich countries not to use booster doses at least until September end, as it is not yet scientifically proven that the shots are necessary. It stated that COVID-19 vaccines should be used in developing countries that have received less than 2% of over 5 billion doses administered.

Many studies have indicated that protection provided by authorized coronavirus vaccines against the highly infectious delta variant decreases months after people have been immunized, however, the shots continue to offer strong protection against severe complications, hospitalization, and death.

Source Credits –

https://www.business-standard.com/article/current-affairs/eu-regulator-evaluating-if-covid-19-vaccine-booster-dose-is-needed-121090601203_1.html

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Tata Elxsi Shares Rise 2% as ISRO Partnership Fuels Investor Optimism

Tata Elxsi Shares Rise 2% as ISRO Partnership Fuels Investor Optimism

By Nikita Chaurasia

In recent turn of events, Tata Elxsi reportedly experienced a positive surge of over 2% in its shares on Thursday as investors welcomed the company's collaboration with the Indian Space Research Organization (ISRO) for the upcoming Gaganyaan Miss...

General Motors passes Ford to become the second-best EV seller in U.S.

General Motors passes Ford to become the second-best EV seller in U.S.

By Nikita Chaurasia

Detroit-based American multinational automaker, General Motors, has reportedly pulled ahead of fellow American rival, Ford Motor, to establish itself as second-biggest seller of all-electric vehicles in the US during the first quarter of 2023. The...

McKinsey commences job cuts focused on non-client serving teams

McKinsey commences job cuts focused on non-client serving teams

By Nikita Chaurasia

McKinsey and Co. a consulting giant entity has decided to start cutting jobs in one of the biggest rounds of layoffs for the company. This is likely to eliminate the jobs of about 2000 employees from work. The layoffs will be focused on support st...